How to synthesize Lorlatinib?

Lorlatinib is an oral small molecule inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1) kinase developed by Pfizer for the treatment of ALK-positive non-small cell lung cancer.

Jan 2,2024  Inhibitors

The Synthetic method of Larotrectinib (LOXO-101)

Larotrectinib (LOXO-101) is the first highly potent and selective small molecule ATP competitive inhibitor of all three TRK kinases (TRKA, TRKB, and TRKC) to enter clinical development.

Jan 2,2024  API

Properties and Applications of Silicone Oil

Silicone oils are constituted of a linear chain of siloxane repeating units (–Si–O) and a variety of side chains (radical side groups).

Jan 2,2024  API

Sodium carbonate: Applications and Security

Sodium carbonate is the disodium carbonate salt with an alkaline base. It is widely used in industry.

Jan 2,2024  API

Polyethylene glycol immunogenicity: anti-polyethylene glycol antibody

Polyethylene glycol (PEG) is a flexible, hydrophilic simple polymer that is physically attached to peptides, proteins, nucleic acids, liposomes, and nanoparticles to reduce renal clearance, block anti

Jan 2,2024  API

The Biological function of Aviptadil

Aviptadil is a synthetic Vasoactive Intestinal Peptide (VIP) that has been studied in respiratory disease conditions.

Jan 2,2024  Biochemical Engineering

The Pharmacokinetics and uses of Teriparatide acetate

The anabolic drug teriparatide acetate has been introduced as a novel therapeutic agent for osteoporosis.

Jan 2,2024  Biochemical Engineering

Synthesis of Ripretinib

Ripretinib was synthesized by construction of a 1,6-naphtholide involving the junction of an α-aryl ester and appropriately functionalized 4-aminopyridine.

Jan 2,2024  Inhibitors

Pralsetinib: Synthesis and Introduction

Pralsetinib (BLU-667) is synthesised using bromopyridine as a raw material by chemical reaction.

Jan 2,2024  Inhibitors

How is Pemigatinib Synthesised?

Pemigatinib is synthesised using pyrrolopyridine as a raw material, firstly by synthesis of Pemigatinib Morpholine Intermediate and then by reduction, cyclisation and other reactions.

Jan 2,2024  Inhibitors
Prev12345678910...Next>  Go to Page